Royalty Pharma Ownership | Who Owns Royalty Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

Royalty Pharma Ownership Summary

Royalty Pharma is owned by 68.69% institutional investors, 13.17% insiders, and 18.15% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.84% of RPRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Royalty Pharma	68.69%	13.17%	18.15%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Morgan stanley	44.13M	9.84%	$1.16B
Vanguard group	38.02M	8.48%	$1.00B
Fmr	27.89M	6.22%	$735.37M
Blackrock	23.02M	5.13%	$606.97M
Baillie gifford	16.35M	3.65%	$431.22M
Viking global investors lp	11.97M	2.67%	$315.65M
Adage capital partners gp	10.93M	2.44%	$288.28M
Swedbank ab	10.81M	2.41%	$285.15M
State street	9.49M	2.11%	$250.17M
Jpmorgan chase	7.74M	1.73%	$204.08M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Siguler guff advisers	3.39M	38.31%	$89.44M
Adar1 capital management	1.18M	5.88%	$31.15M
Cutter capital management, lp	692.30K	5.51%	$18.26M
Advanced portfolio management	240.00K	4.17%	$6.33M
Cm management	160.00K	3.87%	$4.22M
Regal partners	1.18M	3.22%	$31.05M
New south capital management	2.35M	2.77%	$61.94M
Torray investment partners	693.56K	2.73%	$18.29M
Gmt capital	2.43M	2.37%	$64.00M
Menlo advisors	147.88K	2.16%	$3.90M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	4.81M	0.02%	4.81M
Swedbank ab	10.81M	0.38%	2.53M
Blackrock	23.02M	0.01%	1.81M
Brandywine global investment management	1.64M	0.32%	1.64M
Invesco	1.74M	0.01%	1.06M

Top Sellers

Holder	Shares	% Assets	Change
Fmr	27.89M	0.05%	-5.75M
Unisphere establishment	-	-	-5.00M
Manufacturers life insurance company, the	279.85K	0.01%	-2.93M
Marshall wace, llp	-	-	-945.84K
Point72 asset management	-	-	-521.20K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	4.81M	0.02%	4.81M	$126.82M
Brandywine global investment management	1.64M	0.32%	1.64M	$43.17M
Manning & napier advisors	195.85K	0.06%	195.85K	$5.16M
Menlo advisors	147.88K	2.16%	147.88K	$3.90M
Hohimer wealth management	143.91K	0.88%	143.91K	$3.79M

Sold Out

Holder	Change
Tfc financial management	-1.00
Financial gravity asset management	-2.00
Harbor investment advisory	-4.00
Advisornet financial	-10.00
Gradient investments	-19.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	394	3.14%	307,455,539	-2.73%	68	1.40%	214	6.47%	120	-4.76%
Jun 30, 2024	377	-1.57%	316,067,573	2.80%	70	1.49%	201	-8.22%	123	6.03%
Mar 31, 2024	383	4.36%	307,459,490	0.67%	68	1.48%	219	-2.67%	116	7.41%
Dec 31, 2023	367	14.69%	305,416,427	4.62%	68	1.62%	225	32.35%	108	-6.90%
Sep 30, 2023	320	-3.32%	291,943,220	-7.55%	64	1.29%	170	-6.59%	116	6.42%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	11.97M	2.68%	-46.29K
Vanguard Mid Cap Index Institutional	8.08M	1.81%	12.89K
Morgan Stanley Inst Growth I	6.24M	1.39%	-1.19M
Morgan Stanley Growth	6.24M	1.39%	-1.19M
Morgan Stanley Growth SMA	6.24M	1.39%	-1.19M
Vanguard Institutional Extnd Mkt Idx Tr	5.79M	1.29%	-137.78K
MS INVF US Advantage I	5.68M	1.27%	-
MS INVF US Growth I	4.62M	1.03%	35.50K
Fidelity Dividend Growth	4.04M	0.90%	139.90K
Swedbank Robur Aktiefond Pension	3.72M	0.83%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 02, 2024	RIGGS RORY B	-	Sell	$6.71M
Jan 04, 2024	RIGGS RORY B	-	Sell	$983.50K
Jan 03, 2024	RIGGS RORY B	-	Sell	$5.53M
Dec 29, 2023	Avara Management Ltd	-	Sell	$1.85M
Dec 27, 2023	Avara Management Ltd	-	Sell	$1.17M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	3
2023 Q4	-	6
2023 Q3	-	4

RPRX Ownership FAQ

Who Owns Royalty Pharma?

Royalty Pharma shareholders are primarily institutional investors at 68.69%, followed by 13.17% insiders and 18.14% retail investors. The average institutional ownership in Royalty Pharma's industry, Biotech Stocks , is 44.97%, which Royalty Pharma exceeds.

Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (44.13M shares, 9.84%), Vanguard group (38.02M shares, 8.48%), and Fmr (27.89M shares, 6.22%). Together, they hold 24.53% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

Siguler guff advisers is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 38.31% of its assets in 3.39M Royalty Pharma shares, valued at 89.44M$.

Who is the top mutual fund holder of Royalty Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Royalty Pharma shares, with 2.68% of its total shares outstanding invested in 11.97M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools